Download PDF
Geburtshilfe Frauenheilkd 2016; 76(11): 1189-1193
DOI: 10.1055/s-0042-109267
Case Report
GebFra Science
Georg Thieme Verlag KG Stuttgart · New York

Twenty-five-year-old Woman with Bilateral Borderline Ovarian Tumour Desiring to Preserve Fertility – Case Report and Literature Review on the Current State of Fertility Preservation in Women with Borderline Ovarian Tumours

25-jährige Frau mit beidseitigem Borderline-Tumor des Ovars und Wunsch nach Fertilitätserhalt – Fallbericht und Literaturdiskussion über den aktuellen Stand der Fertilitätsprotektion beim ovariellen Borderline-Tumor
S. Findeklee
Department of Obstetrics and Gynaecology, Erlangen University Hospital, Erlangen, Germany
,
L. Lotz
Department of Obstetrics and Gynaecology, Erlangen University Hospital, Erlangen, Germany
,
K. Heusinger
Department of Obstetrics and Gynaecology, Erlangen University Hospital, Erlangen, Germany
,
I. Hoffmann
Department of Obstetrics and Gynaecology, Erlangen University Hospital, Erlangen, Germany
,
R. Dittrich
Department of Obstetrics and Gynaecology, Erlangen University Hospital, Erlangen, Germany
,
M. W. Beckmann
Department of Obstetrics and Gynaecology, Erlangen University Hospital, Erlangen, Germany
› Author Affiliations
Further Information

Publication History

received 09 January 2016
revised 03 May 2016

accepted 24 May 2016

Publication Date:
25 November 2016 (online)

Also available at
   Permissions and Reprints

Abstract

Borderline ovarian tumours are semimalignant tumours occurring unilaterally or bilaterally with a peak incidence among women of reproductive age. Since the affected women often wish to preserve fertility, particular precautions must be taken when counselling the patient and obtaining consent prior to planning an individual treatment. Options for preserving fertility include an organ-sparing surgical procedure and cryopreservation of oocytes and/or ovarian tissue. In this article, we report on a 25-year-old patient with a bilateral seromucinous borderline tumour who desired all fertility-preserving options. In order to perform the procedure without delay, we opted to perform luteal phase stimulation prior to oocyte retrieval. We conclude by discussing the current literature on the state of fertility preservation in the treatment of borderline ovarian tumours.

Zusammenfassung

Borderline-Tumoren des Ovars sind semimaligne ein- oder beidseitig auftretende Tumoren, die ihren Altersgipfel bei Frauen im reproduktiven Alter haben. Da die betroffenen Frauen häufig einen Kinderwunsch hegen, ergeben sich besondere Notwendigkeiten der Aufklärung vor der Planung einer individuellen Therapie. Möglichkeiten des Erhalts der Fertilität sind ein organschonendes operatives Vorgehen sowie die Kryokonservierung von Eizellen und/oder Eierstockgewebe. Wir berichten über eine 25-jährige Patientin mit beidseitigem seromuzinösem Borderline-Tumor, die alle Optionen des Fertilitätserhalts wünschte. Um die Operation zeitnah durchführen zu können, entschieden wir uns für eine Lutealphasenstimulation vor der Follikelpunktion. Abschließend diskutieren wir die aktuelle Literatur zum Stand der Fertilitätsprotektion beim ovariellen Borderline-Tumor.

Key words

borderline tumour - fertility preservation - future wish for child - luteal phase stimulation - ovarian cryopreservation

Schlüsselwörter

Borderline-Tumor - Fertilitätserhalt - späterer Kinderwunsch - Lutealphasenstimulation - Kryokonservierung von Ovargewebe und Eizellen

Supporting Information

 

  • References

  • 1 Harlow BL, Weiss NS, Lofton S. Epidemiology of borderline ovarian tumours. J Natl Cancer Inst 1987; 78: 71-74
    PubMedSearch in Google Scholar
  • 2 Scully RE. World Health Organization. International Classification of Tumours. Histological Typing of ovarian Tumors. 2nd. ed. Berlin, Heidelberg, New York, Tokio: Springer; 1999
    CrossrefSearch in Google Scholar
  • 3 Modugno F, Ness RB, Wheeler JE. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol 2001; 11: 568-574
    CrossrefPubMedSearch in Google Scholar
  • 4 Nikrui N. Survey of clinical behavior of patients with borderline tumors of the ovary. Gynecol Oncol 1981; 12: 107-119
    CrossrefPubMedSearch in Google Scholar
  • 5 Patrono MG, Minig L, Diaz-Padilla I et al. Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment. Ecancermedicalscience 2013; 7: 379
    PubMedSearch in Google Scholar
  • 6 Uzan C, Kane A, Rey A et al. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol 2010; 21: 55-60
    CrossrefPubMedSearch in Google Scholar
  • 7 Daraï E, Fauvet R, Uzan C et al. Fertility and borderline ovarian tumour: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update 2013; 19: 151-166
    CrossrefPubMedSearch in Google Scholar
  • 8 Parazzini F, Negri E, La V et al. Treatment for fertility and risk of ovarian tumours of borderline malignancy. Gynecol Oncol 1998; 68: 226-228
    CrossrefPubMedSearch in Google Scholar
  • 9 von Wolff M, Montag M, Dittrich R et al. Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkinʼs lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet 2011; 284: 427-435
    CrossrefPubMedSearch in Google Scholar
  • 10 Findeklee S, Lotz L, Heusinger K et al. Fertility protection in female oncology patients: how should patients be counseled?. Geburtsh Frauenheilk 2015; 75: 1243-1249
    Thieme ConnectPubMedSearch in Google Scholar
  • 11 Trillsch F, Mahner S, Ruetzel J et al. Clinical management of borderline ovarian tumors. Expert Rev Anticancer Ther 2010; 10: 1115-1124
    CrossrefPubMedSearch in Google Scholar
  • 12 Vasconcelos I, de Sousa Mendes M. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk. Eur J Cancer 2015; 51: 620-631
    CrossrefPubMedSearch in Google Scholar
  • 13 du Bois A, Petru E, Meier W et al. S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, Juni 2013. Online: http://www.awmf.org last access: 02.01.2016
    PubMed
  • 14 Lee MC, Gray J, Han HS et al. Fertility and reproductive considerations in premenopausal patients with breast cancer. Cancer Control 2010; 17: 162-172
    PubMedSearch in Google Scholar
  • 15 Li A, Pasternak M, Duke C et al. The effect of practitioner education on fertility preservation awareness, perception and clinical practice. Obstet Gynecol 2015; 125: 8-9
    PubMedSearch in Google Scholar
  • 16 Zanetta G, Rota S, Chiari S et al. Behaviour of borderline tumours with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001; 19: 2656-2664
    PubMedSearch in Google Scholar
  • 17 Trillsch F, Mahner S, Vettorazzi E. Surgical staging and prognosis in serous borderline ovarian tumors (BOT): a subanalysis of the AGO ROBOT study. Br J Cancer 2015; 112: 660-666
    CrossrefPubMedSearch in Google Scholar
  • 18 Shim SH, Kim SN, Jung PS et al. Impact of surgical staging on prognosis in patients with borderline ovarian tumours: a meta-analysis. Eur J Cancer 2016; 54: 84-95
    CrossrefPubMedSearch in Google Scholar
  • 19 du Bois A, Ewald-Riegler N, de Gregorio N et al. Borderline tumours of the ovary: a cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group. Eur J Cancer 2013; 49: 1905-1914
    CrossrefPubMedSearch in Google Scholar
  • 20 Denschlag D, von Wolff M, Amant F et al. Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery. Gynecol Obstet Invest 2010; 70: 160-165
    CrossrefPubMedSearch in Google Scholar
  • 21 Beiner ME, Gotlieb WH, Davidson B et al. Infertility treatment after conservative management of borderline ovarian tumours. Cancer 2001; 92: 320-325
    CrossrefPubMedSearch in Google Scholar
  • 22 Fortin A, Morice P, Thoury A et al. Impact of infertility drugs after treatment of borderline ovarian tumours: results of a retrospective multicenter study. Fertil Steril 2007; 87: 591-596
    CrossrefPubMedSearch in Google Scholar
  • 23 Basille C, Olivennes F, Le C et al. Impact of gonadotropins and steroid hormones on tumour cells derived from borderline ovarian tumours. Hum Reprod 2006; 21: 3241-3245
    CrossrefPubMedSearch in Google Scholar
  • 24 von Wolff M, Thaler CJ, Frambach T et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2009; 92: 1360-1365
    CrossrefPubMedSearch in Google Scholar
  • 25 Simi G, Obino ME, Casarosa E et al. Different stimulation protocols for oocyte cryopreservation in oncological patients: a retrospective analysis of single university centre. Gynecol Endocrinol 2015; 31: 966-970
    CrossrefPubMedSearch in Google Scholar
  • 26 Nekkebroeck J, Stoop D, Devroey P. A preliminary profile of women opting for oocyte cryopreservation for non-medical reasons. Hum Reprod 2010; 25: i15-i16
    PubMedSearch in Google Scholar
  • 27 Rosendahl M, Greve T, Andersen CY. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet 2013; 30: 11-24
    CrossrefPubMedSearch in Google Scholar
  • 28 Fain-Kahn V, Poirot C, Uzan C et al. Feasibility of ovarian cryopreservation in borderline ovarian tumours. Hum Reprod 2009; 24: 850-855
    CrossrefPubMedSearch in Google Scholar
  • 29 Donnez J, Dolmans MM, Pellicer J et al. Fertility preservation for age-related fertility decline. Lancet 2015; 385: 506-507
    PubMedSearch in Google Scholar
  • 30 Lotz L, Montag M, van der Ven H et al. Xenotransplantation of cryopreserved ovarian tissue from patients with ovarian tumors into SCID mice—no evidence of malignant cell contamination. Fertil Steril 2011; 95: 2612-2614
    CrossrefPubMedSearch in Google Scholar
  • 31 Cho HY, Kyung MS. CA 19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched-case control study. Med Sci Monit 2014; 20: 1334-1339
    CrossrefPubMedSearch in Google Scholar
  • 32 Barnhill DR, OʼConnor DM. Management of ovarian neoplasms of low malignant potential. Oncology (Williston Park) 1991; 5: 21-26 discussion 26, 28, 31–32
    PubMedSearch in Google Scholar